Triphasic norgestimate-ethinyl estradiol for treating dysfunctional uterine bleeding

Obstetrics and Gynecology

Volumn 96, Issue 6, 2000, Pages 913-920

  Davis, Ann ^a   Godwin, Amy ^b   Lippman, Joel ^b   Olson, William ^b   Kafrissen, Michael ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b Ortho McNeil Pharmaceutical Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL PLUS NORGESTIMATE; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PLACEBO;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERMENORRHEA; MAJOR CLINICAL STUDY; MENORRHAGIA; METRORRHAGIA; MULTICENTER STUDY; ORAL CONTRACEPTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; UTERUS BLEEDING; WEIGHT GAIN;

ADOLESCENT; ADULT; CONTRACEPTIVES, ORAL, SYNTHETIC; DOUBLE-BLIND METHOD; ETHINYL ESTRADIOL; FEMALE; HUMANS; MENSTRUATION DISTURBANCES; MIDDLE AGED; NORGESTREL; TREATMENT OUTCOME;

EID: 0033748855     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(00)01029-2     Document Type: Article

References (11)

1. Abnormal uterine bleeding in the perimenopause
2. Clinical manifestations and treatment of dysfunctional uterine bleeding
3. Abnormal uterine bleeding
4. Management of abnormal uterine bleeding
5. Dysfunctional uterine bleeding
6. Efficacy and safety of a monophasic and a triphasic oral contraceptive containing norgestimate
7. Cycle control with triphasic norgestimate and ethinyl estradiol, a new oral contraceptive agent
8. Clinical evaluation of a new triphasic oral contraceptive: Norgestimate and ethinyl estradiol
9. Assessments of menstrual blood loss using a pictorial chart
10. The analysis of vaginal bleeding patterns induced by fertility regulating methods